Your session is about to expire
← Back to Search
MyProstateScore 2.0 for Prostate Cancer
N/A
Waitlist Available
Research Sponsored by Qure Healthcare, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up [9 months]
Awards & highlights
Study Summary
This trial will look at how well LynxDx's new MPS 2.0 Test can detect prostate cancer early. It will collect patient data to measure the test's clinical utility.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ [9 months]
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~[9 months]
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Baseline levels of variation in the assessment, surveillance, and management of patients at high risk for prostate cancer among all study participants.
Differences between expected quality of care and actual quality of care
Differences in evidence-based decision making
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: MyProstateScore 2.0Experimental Treatment1 Intervention
The intervention will receive information regarding the MyProstateScore 2.0 test and will be given the test results in their round of CPV information and for each sample that they submit.
Group II: Control arm - Baseline comparisonActive Control1 Intervention
The Control group treats their simulated patients using standard practice and has no introduction to the new MyProststate 2.0 test.
Find a Location
Who is running the clinical trial?
Qure Healthcare, LLCLead Sponsor
21 Previous Clinical Trials
3,813 Total Patients Enrolled
2 Trials studying Prostate Cancer
451 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You often see patients who are at risk of getting prostate cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Control arm - Baseline comparison
- Group 2: MyProstateScore 2.0
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this trial currently seeking participants?
"Affirmative. Clinicaltrials.gov reveals this research is currently enrolling participants, with the study first being posted on March 31st 2023 and most recently modified on June 15th of the same year. 150 people are needed to be recruited from a single location for participation in this trial."
Answered by AI
How many participants have been selected to take part in this clinical experiment?
"That is correct. Clinicaltrials.gov shows that the trial was first published on March 31st 2023, and it's actively enrolling around 150 participants across a single site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger